The European Commission’s proposal for a horizontal regulation that applies to all artificial intelligence (AI) products has been largely met with skepticism from stakeholders across the medtech industry. So far, much of this criticism has focused on the overlap between the AI Act and other regulations in the EU, such as the sector-specific Medical Device and In Vitro Diagnostic Regulations (MDR/IVDR).
A wider perspective on the AI Act and its “fundamental problem” was offered by a philosopher and computer ethics professor during a recent webinar on digital health and AI, hosted...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?